Cempra Shareholder Sues Over CEO's Retirement Package
By Ryan Boysen ( August 4, 2017, 5:29 PM EDT) -- A shareholder of the ailing drug manufacturer Cempra Inc. hit the company's board and since-retired CEO with a derivative suit in Delaware Chancery Court on Thursday, alleging the company's leadership misled investors about the safety of its flagship drug and then improperly approved a "lavish" payout when the CEO resigned "in disgrace."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.